AOD 9604 With Retatrutide: Evidence, Safety, and UK Regulatory Status AOD 9604 with retatrutide is a combination increasingly discussed in weight-loss and body-composition circles, yet neither compound holds a Marketing Authorisation from the MHRA or EMA for use in the UK
Adipose depots differ in vascularization, innervation, adipocyte size, receptor expression, inflammatory state, and metabolic function
This is why supplementation is often recommended
Its 100% quackery, 100% useless and 100% dangerous in the wrong hands
What Are B12 Injections and Who Needs Them
Patients should be counseled to promptly report symptoms of pancreatitis (severe abdominal pain, sometimes radiating to the back), gallbladder disease, or signs of acute kidney injury